AS Latvijas Juras medicinas centrs (UOM) — Capital Reinvestment Ratio
AS Latvijas Juras medicinas centrs (UOM) has a Capital Reinvestment Ratio of 0.91x as of September 2025, meaning it reinvests 1% of its operating cash flow (€474.45K) in capital expenditures (€430.89K). See UOM equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AS Latvijas Juras medicinas centrs Capital Reinvestment Ratio (2015–2024)
This chart tracks AS Latvijas Juras medicinas centrs's Capital Reinvestment Ratio across 10 annual periods. Check UOM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs (2015–2024)
Year-by-year Capital Reinvestment Ratio for AS Latvijas Juras medicinas centrs from 2015 to 2024. For live market cap and broader valuation context, see UOM company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.72x | €605.02K | €436.21K | ▼ -44.4% |
| 2023 | 1.30x | €1.91 Million | €2.48 Million | ▲ +125.1% |
| 2022 | 0.58x | €1.09 Million | €629.72K | ▼ -78.3% |
| 2021 | 2.65x | €418.24K | €1.11 Million | ▲ +277.5% |
| 2020 | 0.70x | €732.71K | €515.12K | ▲ +52.6% |
| 2019 | 0.46x | €412.86K | €190.16K | ▲ +219.4% |
| 2018 | 0.14x | €599.57K | €86.45K | ▼ -88.6% |
| 2017 | 1.27x | €478.41K | €605.51K | ▼ -38.4% |
| 2016 | 2.06x | €418.49K | €860.13K | ▲ +186.4% |
| 2015 | 0.72x | €362.36K | €260.06K | — |